Conference Call Participants. Matthew Martino - Goldman Sachs Group, Inc., Research Division Fatima Boolani - Citigroup Inc. Exchange Research John DiFucci - Guggenheim Securities ...
Regulatory News: ABIONYX Pharma, (FR0012616852 – ABNX – eligible for PEA PME), a next-generation biopharmaceutical company developing innovative therapies in sepsis and critical care based on an ...